Home

Ipca Laboratories Ltd PE Ratio

Image

Ipca Laboratories Ltd

NSE: IPCALAB

PE

60

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Ipca Laboratories Ltd is 60 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 57.4 on March 2024 . This represents a CAGR of 14.71% over 5 years.
  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1566 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Ipca Laboratories Ltd

No data available

Company Fundamentals for Ipca Laboratories Ltd

Image

Ipca Laboratories Ltd

NSE: IPCALAB

Share Price

₹ 1566.75

-21.55 (-1.36%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Ipca Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ipca Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251588.3
13 Jan 20251579.8
10 Jan 20251631.3
09 Jan 20251661.2
08 Jan 20251693.5
07 Jan 20251735.15
06 Jan 20251718.7
03 Jan 20251733.4
02 Jan 20251743.25
01 Jan 20251696.85

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

che

Weakness

4

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Ipca Laboratories Ltd

Asset Value vs Market Value of Ipca Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Ipca Laboratories Ltd40295
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Ipca Laboratories Ltd Explained

``

40295

Market cap

661

Earnings

60.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Ipca Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Ipca Laboratories Ltd

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

Ipca Laboratories Ltd News Hub

Ipca Laboratories Ltd soars 2.3%, rises for third straight session

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs 1416.1, up

Read more

2024-08-21 00:00:00

Ipca Laboratories consolidated net profit rises 18.07% in the June 2024 quarter

Net profit of Ipca Laboratories rose 18.07% to Rs 192.24 crore in the quarter ended June 2024 as aga

Read more

2024-08-13 00:00:00

Ipca Laboratories Ltd gains for fifth session

Ipca Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1378.5

Read more

2024-08-12 00:00:00

Ipca Laboratories Ltd soars 2.1%

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1368.6

Read more

2024-08-08 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ipca Laboratories Ltd

What is the current PE Ratio of Ipca Laboratories Ltd?

The Current PE Ratio of Ipca Laboratories Ltd is 60.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Ipca Laboratories Ltd last year?

The PE Ratio of Ipca Laboratories Ltd was 43.61 last year, now the PE ratio is 60.0, showing a year-on-year growth of 37.6%.

What does the PE Ratio of Ipca Laboratories Ltd indicate about its stock?

The PE Ratio of Ipca Laboratories Ltd is 60.0. This ratio indicates that investors are willing to pay 60.0 times the earnings per share for each share of Ipca Laboratories Ltd.

What is the PE Ratio Growth of Ipca Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ipca Laboratories Ltd grew by 37.6% whereas, the EPS ratio grew by 19.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions